Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
Screenshot preview · Scroll to view the full email
Archived for design inspiration. Original email and brand assets belong to their respective owners. Design observations describe the creative; they are not campaign results.
More emails like this
Explore other emails with shared design, campaign, or industry tags.
Novo NordiskView brand email archive
